BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Andrade AL, Toscano CM, Minamisava R, Costa PS, Andrade JG. Pneumococcal disease manifestation in children before and after vaccination: what's new? Vaccine 2011;29 Suppl 3:C2-14. [PMID: 21896349 DOI: 10.1016/j.vaccine.2011.06.096] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 1.6] [Reference Citation Analysis]
Number Citing Articles
1 Shetty AK, Maldonado YA. Current Trends in Streptococcus pneumoniae Infections and Their Treatment. Curr Pediatr Rep 2013;1:158-69. [DOI: 10.1007/s40124-013-0021-9] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
2 Key L, Hijano DR, Arnold SR. A Toddler With Fever, Melena, and Renal Failure. Clin Pediatr (Phila) 2019;58:367-70. [PMID: 30501507 DOI: 10.1177/0009922818816505] [Reference Citation Analysis]
3 Nunes SEA, Minamisava R, Vieira MADS, Itria A, Pessoa VP Junior, Andrade ALSS, Toscano CM. Hospitalization costs of severe bacterial pneumonia in children: comparative analysis considering different costing methods. Einstein (Sao Paulo) 2017;15:212-9. [PMID: 28767921 DOI: 10.1590/S1679-45082017GS3855] [Cited by in Crossref: 2] [Article Influence: 0.4] [Reference Citation Analysis]
4 Esposito S, Principi N. Pharmacotherapy for pneumococcal infections: an update. Expert Opin Pharmacother 2013;14:65-77. [PMID: 23256539 DOI: 10.1517/14656566.2013.756867] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
5 Song JY, Nahm MH, Moseley MA. Clinical implications of pneumococcal serotypes: invasive disease potential, clinical presentations, and antibiotic resistance. J Korean Med Sci 2013;28:4-15. [PMID: 23341706 DOI: 10.3346/jkms.2013.28.1.4] [Cited by in Crossref: 91] [Cited by in F6Publishing: 86] [Article Influence: 10.1] [Reference Citation Analysis]
6 Proesmans M, Gijsens B, Van de Wijdeven P, De Caluwe H, Verhaegen J, Lagrou K, Van Even E, Vermeulen F, De Boeck K. Clinical outcome of parapneumonic empyema in children treated according to a standardized medical treatment. Eur J Pediatr 2014;173:1339-45. [PMID: 24838799 DOI: 10.1007/s00431-014-2319-1] [Cited by in Crossref: 11] [Cited by in F6Publishing: 6] [Article Influence: 1.4] [Reference Citation Analysis]
7 Abrams CM, Hijano DR, Bagga B. Abdominal Pain in the Setting of Atypical Hemolytic Uremic Syndrome Caused by Streptococcus pneumoniae Pneumonia. Glob Pediatr Health 2018;5:2333794X18762866. [PMID: 29552602 DOI: 10.1177/2333794X18762866] [Reference Citation Analysis]
8 Yang H, Gong Y, Zhang H, Etobayeva I, Miernikiewicz P, Luo D, Li X, Zhang X, Dąbrowska K, Nelson DC, He J, Wei H. ClyJ Is a Novel Pneumococcal Chimeric Lysin with a Cysteine- and Histidine-Dependent Amidohydrolase/Peptidase Catalytic Domain. Antimicrob Agents Chemother 2019;63:e02043-18. [PMID: 30642930 DOI: 10.1128/AAC.02043-18] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.7] [Reference Citation Analysis]
9 Bautista-Márquez A, Richardson V, Ortiz-Orozco O, Luna-Cruz ME, Carnalla-Barajas MN, Echaniz-Avilés G, Bobadilla-del Valle M, Martínez-Medina L, Montalvo-Vázquez AM, de la Re-Montaño N, Anchondo-Martínez I, Tinoco-Favila JC, Martínez-Aguilar G, Yberri-Zárate I, Girón-Hernández JA, Sifuentes-Osornio J, Guerrero ML, Ruiz-Palacios GM. Prevalence of pneumococcal disease, serotype distribution, and antimicrobial susceptibility in Mexican children younger than 5 years of age. Arch Med Res 2013;44:142-50. [PMID: 23291380 DOI: 10.1016/j.arcmed.2012.12.005] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 1.1] [Reference Citation Analysis]
10 Martínez ME, Benítez J, Leguizamón LB, López OH, Grenón SL, Mollerach ME, von Specht MH. [Pneumococcal osteoarticular infections in children admitted to a Pediatric Reference Hospital from Misiones, Argentina. Thirteen years of surveillance]. Rev Argent Microbiol 2021:S0325-7541(20)30100-0. [PMID: 33541757 DOI: 10.1016/j.ram.2020.10.003] [Reference Citation Analysis]
11 Yang H, Luo D, Etobayeva I, Li X, Gong Y, Wang S, Li Q, Xu P, Yin W, He J, Nelson DC, Wei H. Linker Editing of Pneumococcal Lysin ClyJ Conveys Improved Bactericidal Activity. Antimicrob Agents Chemother 2020;64:e01610-19. [PMID: 31767724 DOI: 10.1128/AAC.01610-19] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
12 Luo D, Huang L, Gondil VS, Zhou W, Yang W, Jia M, Hu S, He J, Yang H, Wei H. A Choline-Recognizing Monomeric Lysin, ClyJ-3m, Shows Elevated Activity against Streptococcus pneumoniae. Antimicrob Agents Chemother 2020;64:e00311-20. [PMID: 32958710 DOI: 10.1128/AAC.00311-20] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
13 Wiese AD, Griffin MR, Zhu Y, Mitchel EF Jr, Grijalva CG. Changes in empyema among U.S. children in the pneumococcal conjugate vaccine era. Vaccine 2016;34:6243-9. [PMID: 27832918 DOI: 10.1016/j.vaccine.2016.10.062] [Cited by in Crossref: 35] [Cited by in F6Publishing: 29] [Article Influence: 5.8] [Reference Citation Analysis]
14 Silva MD, Oliveira H, Faustino A, Sillankorva S. Characterization of MSlys, the endolysin of Streptococcus pneumoniae phage MS1. Biotechnol Rep (Amst) 2020;28:e00547. [PMID: 33204659 DOI: 10.1016/j.btre.2020.e00547] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
15 Quiviger S, Fléchelles O, Cécile W, Hatchuel Y. Syndrome hémolytique et urémique secondaire à Streptococcus pneumoniae de sérotype 3. Archives de Pédiatrie 2012;19:599-602. [DOI: 10.1016/j.arcped.2012.03.013] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
16 Spencer DA, Thomas MF. Necrotising pneumonia in children. Paediatr Respir Rev 2014;15:240-5; quiz 245. [PMID: 24268096 DOI: 10.1016/j.prrv.2013.10.001] [Cited by in Crossref: 4] [Cited by in F6Publishing: 13] [Article Influence: 0.4] [Reference Citation Analysis]